DUBLIN--(BUSINESS WIRE)--The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering. The European market for life science tools and reagents and ...

LOS ANGELES--(BUSINESS WIRE)--BioTools Innovator, the first accelerator dedicated to supporting life science tools and diagnostics startups, announced today that 20 companies have been selected to ...

BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and biotech companies dropped after pandemic-related overspending, and demand in ...

Adaptive Biotechnologies is the top performing life sciences tools and services stock YTD The S&P healthcare index ( XLV) saw ...

The broad healthcare sector accounts for roughly one-fifth of the U.S. economy and continues to expand. While most attention tends to go to the direct-care segment, the life-sciences industry is an ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how life sciences tools & services stocks fared in Q3, starting ...

Bioprocessing is set to gain momentum in 2025, with Life Sciences Tools recovery projected by mid-year and robust growth by Q4. Danaher (DHR) and Thermo Fisher (TMO) will report Q4 earnings next week ...

Investing.com -- The life sciences and diagnostic tools sector is poised for growth in 2026, with several companies well-positioned to capitalize on improving market conditions. According to Bank of ...

Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate of ...

On Friday, Avantor Inc (NYSE:AVTR) reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion. Foreign currency translation and ...

Canaccord analyst Kyle Mikson raised the firm’s price target on Caris Life Sciences (CAI) to $30 from $28 and keeps a Hold rating on the shares.